24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Financial Issues
Resources
Basic Information
CalculatorsMoney in Life ContextMoney ManagementManaging DebtInsurance & Financial Risk ManagementHousingAutomobilesInvestmentsRetirementEstate PlanningTaxesLatest News
Pandemic Job Losses Leaving Many Americans Uninsured: SurveyAnother COVID Plague: Big Surprise Medical Bills for SurvivorsBreast Cancer Takes Big Financial Toll on Some Young PatientsEmergency Transport Can Surprise Many With Big Bills'Major Financial Hardship' Hits Most Patients Battling Advanced Colon CancerCosts Would Keep 1 in 7 Americans From Seeking COVID-19 TreatmentCoping With Budget Stress During the PandemicYoung Breast Cancer Patients Struggle Financially, Even When InsuredFewer American Families Weighed Down by Medical Bills1 in 5 Insured Hit With Surprise Bills for SurgeryA Quarter of Middle-Aged Americans Worry They Can't Afford Health CareAmericans Toss Out Nearly a Third of Food at HomeDespite Obamacare, Number in U.S. Who Can't Afford to See Doctor Keeps RisingFor Cancer Survivors, Financial Hardship Is Common: SurveyAs Minimum Wage Rises, Suicide Rates FallADHD in Childhood May Mean Financial Struggles LaterOut-of-Pocket Costs for Medicare Recipients Will Rise in New YearHeart Medicines Priced Out of Reach for Many AmericansAHA News: Areas Hit Hardest by Recession Saw Jump in Heart Death RatesHeart Disease Took Big Toll in Counties Hardest Hit by RecessionHealth Tip: Managing Financial StressMany on Medicare Still Face Crippling Medical BillsMany Cancer Docs Don't Discuss Costs of Pricey Gene TestsFor Seniors, Financial Woes Can Be Forerunner to Alzheimer'sConfusing Medical Bills Tied to Money Woes in Cancer SurvivorsWhen Income Drops, Young Adults' Brains May SufferHealth Insurance Premiums Are Soaring for ManyWhat Do Hospital Cyber Attackers Want to Know About You?Cancer Patients Turning to Crowdfunding to Help Pay Medical CostsPaperwork, High Costs Could Mean Worse Survival for Lung Cancer PatientsCan a Budget Make You Happier?
Questions and AnswersLinks
Related Topics

Many Cancer Docs Don't Discuss Costs of Pricey Gene Tests

HealthDay News
by -- Robert Preidt
Updated: Nov 1st 2019

new article illustration

FRIDAY, Nov. 1, 2019 (HealthDay News) -- Fighting cancer can be a long, hard battle, not to mention expensive. Now, new research shows that a quarter of oncologists don't discuss the cost of expensive tests with their patients.

Genomic tests on cancer cells can help determine which types of treatment might work, and which ones might not. However, such testing can be expensive, and not all tests and related treatments are covered by health insurance, the researchers noted.

Costs of cancer care are rising, and there are increasing concerns about high patient out-of-pocket costs for cancer treatment.

Discussions with their oncologists can help patients make informed decisions about treatment and prepare for potentially high costs. So, the study authors wanted to find out how often oncologists discuss costs of genomic testing and treatment with patients.

They analyzed data from 1,220 U.S. oncologists who took part in a national survey on precision medicine in cancer care.

Half of them said they often discussed the likely costs of testing and related treatments with patients; 26.3% said they sometimes discussed costs; and 23.7% said they never or rarely discussed costs.

Further investigation showed that oncologists trained in genomic testing or who worked in practices with electronic medical record alerts for genomic tests were about two times more likely to discuss costs with patients sometimes or often.

Other factors associated with being more likely to discuss costs with patients included: treating patients with solid tumors; using next-generation sequencing gene panel tests; having higher patient volume; and working in practices with higher percentages of patients with Medicaid, private insurance or no insurance.

"Initiating a discussion about the expected out-of-pocket costs of genomic testing and related treatment is a necessary first step, but is not sufficient to ensure that patients and their families can make fully informed decisions about treatment options," said lead researcher Robin Yabroff, from the American Cancer Society.

"In the context of rising costs of cancer care, interventions targeting modifiable physician and practice factors may help increase the frequency of physician-patient cost discussions, contributing to more informed patient decisions and higher-quality cancer care," the researchers said in a society news release.

The study was published Nov. 1 in the Journal of the National Cancer Institute.

More information

The American Cancer Society has more on the costs of cancer treatment.